Head of CMC and Product Development
Tom serves as Equillium’s Head of CMC and Product Development. He has more than 34 years of accomplishments in the discovery and development of protein therapeutics. Tom is currently a consultant or scientific advisor to more than 20 companies. Tom has recently helped start several companies, including helping them license in clinical stage molecules. Prior to consulting, Tom worked at Amgen for 28 years and was the first Vice President of Amgen Protein Science. His teams were responsible for the majority of the current Amgen product portfolio and late stage clinical programs. Tom was the lead scientist in the development of Nplate®, a treatment of thrombocytopenia. His critical role in the discovery and process development of G-CSF (Neupogen) is widely recognized.
Tom received his Bachelor of Science in Genetics from the U.C. Davis, a Master of Arts in Microbiology from UCLA and a Master of Science in Soil Science from U.C. Davis. Tom is a widely published author and holds over 45 patents in drug discovery and development.